SoftMedx Healthcare Limited

SoftMedx Healthcare Limited

0648.HK
SoftMedx Healthcare LimitedHK flagHong Kong Stock Exchange
2.85
HKD
+0.47
- -
305.28MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
56.11
39.09
28.55
10.33
7.39
3.57
2.46
0.59
0.1
2.07
3.15
3.35
0.12
Basic EPS, GAAP
-62.03
-27.99
-97.94
-31.61
-14.02
-4.05
-4.72
-3.12
-1.61
-1.18
0.77
20.02
0.01
Free Cash Flow per Basic Share
28.4
-32.55
-38.48
-10.63
-3.74
-1.3
-1
-0.61
-0.44
-0.21
-0.28
0.24
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-409.43
109.4
37.13
21.62
-0.72
-3.55
-8.6
-17.41
-18.97
-20.63
-19.87
0.15
0.05
Tangible Book Value per Share
244.77
262.33
109.22
19.31
-2.53
-6.55
-16.49
-19.4
-19.93
-21.1
-19.87
0.15
0.05
Basic Weighted Avg Shares
2
2
4
10
16
16
16
16
16
16
16
16
578
Sales/Revenue/Turnover
111
85
127
102
121
58
40
10
2
34
51
55
68
Operating Margin (%)
32.96
1.05
-127.46
-92.7
-68.68
-90.4
-106.96
-330.57
-1,238.79
-27.5
11.76
15.67
16.89
Depreciation Expense
31
10
9
10
6
3
7
2
1
2
1
1
- -
Net Income, GAAP
-123
-61
-437
-311
-229
-66
-77
-51
-26
-19
13
326
7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
12.93
0.5
26.44
Profit Margin (%)
-110.55
-71.6
-343.07
-305.94
-189.67
-113.48
-191.71
-528.71
-1,546.5
-56.94
24.37
597.22
10.18
Working Capital
206
229
36
36
-130
-106
-173
-184
-255
-348
-342
-2
27
LT Debt
- -
101
166
185
92
94
101
135
77
2
3
1
- -
Total Equity
498
587
552
320
-28
-94
-264
-316
-325
-344
-324
2
27
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
151.06
19.89
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-47.42
18,021.53
20.85
Return on Common Equity (%)
- -
- -
-215.87
-164.57
- -
- -
- -
- -
- -
- -
- -
- -
46.55

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
119.76%
183.57%
1,015.88%
Free Cash Flow
-40.32%
-39.01%
39.09%
Net Income, GAAP
202.63%
434.03%
-97.87%
Sales/Revenue/Turnover
172.8%
377.68%
24.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
51
2024
- -
- -
- -
- -
55
2025
- -
- -
- -
- -
68

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.77
2024
- -
- -
- -
- -
20.02
2025
- -
- -
- -
- -
0.01

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Lin Pinzhuo
Full Time Employees
20
Sector
Healthcare
Industry
Medical - Care Facilities
Address
China Hong Kong Tower Wan Chai Hong Kong
IPO Date
Jan 4, 2000
Website
648.com.hk
Business
SoftMedx Healthcare Limited (Ticker: 0648.HK) operates as a medical and well-being-focused distributor and service provider in Hong Kong, with a broader footprint in PRC-related activities. The company centers on the distribution of medical and healthcare equipment and related products, complemented by services linked to operation and maintenance of medical devices, as part of its core business portfolio. Main products and services - Medical equipment distribution: distribution of diagnostic, monitoring, and therapeutic devices to hospitals, clinics, and ancillary healthcare providers; after-sales support and warranty services where applicable. - Healthcare product sales: sale of pharmaceutical and health-related products; provision of related consumables, accessories, and ancillary items used in medical care settings. - Medical equipment leasing and operation services: leasing arrangements for medical devices to healthcare facilities; management and operation support for leased equipment, including provisioning of service levels and maintenance. - Medical laboratory and diagnostic support services: outsourcing or on-site laboratory testing services linked to the use of distributed equipment; quality control and data reporting tied to device usage. - Health management and preventive care-related services: programs or services aimed at health management, wellness, and preventive care, leveraging the company’s product ecosystem. - Related services: equipment installation, calibration, maintenance, repairs, and training for medical personnel; regulatory and compliance support tied to product deployments. Geographic operations and market reach - Hong Kong: primary market for distribution, services, and support activities; aligns with regulatory and healthcare system requirements. - PRC-related markets: engages in activities connected to the PRC market through subsidiaries or partnerships, focusing on medical network services, leasing, operation of medical equipment, and related support. - International outreach: potential partnerships or channels that extend product and service delivery beyond Hong Kong and PRC, subject to market conditions and regulatory considerations. Corporate structure and history - Founding year: 1989 - Headquarters: Hong Kong, with principal offices in Sheung Wan (Infinitus Plaza) and related addresses as disclosed in regulatory filings. - Name history: rebranded from China Wah Yan Healthcare Limited to SoftMedx Healthcare Limited in March 2023 - Ownership and corporate relationships: operates through subsidiaries focused on medical and well-being activities; maintains reporting lines and governance consistent with Hong Kong-listed company standards. Recent major changes and strategic developments - Debt restructuring completion: completes a restructuring plan that transitioned from net liabilities to a more stable net asset position, enabling continued investment in core distribution activities and service offerings (as disclosed in public market updates). - Trading arrangements and market resumption steps: undertakes steps to resume or adjust trading arrangements in line with regulatory guidance, signaling ongoing operational stability and readiness to pursue growth opportunities. - Strategic refinements: ongoing evaluation of partnerships and alliances to enhance distribution reach, product breadth, and service capabilities; potential divestitures or reorganizations aligned with optimizing capital structure and focus on core medical equipment distribution and related services. Industry context and value proposition - Industry: medical equipment distribution, healthcare product sales, and related services within Hong Kong and connected markets. - Business segments: medical and well-being products distribution; medical equipment leasing and operation services; support services including installation, maintenance, and training; laboratory and diagnostic support services. - Target customers: healthcare providers, hospitals, clinics, and other facilities requiring medical devices, consumables, and related services. Foundational information and disclosures - The company maintains a regulatory and investor relations presence in Hong Kong, with filings and notices detailing financials, strategic updates, and governance matters in line with HKEX and OTC market disclosures. Note: This description synthesizes publicly available information from regulatory filings, market disclosures, and credible financial data sources related to SoftMedx Healthcare Limited (0648.HK) to present a current, comprehensive view of its core activities, product set, geographic footprint, and recent strategic developments. Citations available upon request.